EN
Be the global leader of T cell cancer immunotherapy
 
Company History
2016.08
TCRCure founded
TCRCure Chongqing R&D center established
Obtain angel investment from professional investment institutions.
2016.11
2017.05
TCRCure US center established.
Planned for 20+ cell therapy related IP assets
Completed preclinical studies for 5 pipeline products
2018.01
2018.04
POC clinical trial started: TCR-T therapy for cervical and head/neck cancer
Obtain series A funding from professional pharmaceutical factories and investment institutions
TCRCure US and China GMP Center started construction.
2019.01
2019.01
POC clinical trial started in Xinqiao Hospital: TCR-T with secreted PD1 products for cervical and nasopharynx cancer therapy。
POC clinical trial started in Sun Yat-sen University Cancer Center: TCR-T product for nasopharynx cancer therapy.
2019.08
2019.12
TCRCure US and China GMP Center completed.
Two clinical trials for cervical and nasopharyngeal cancer were conducted in China
  • 2016.08
    TCRCure founded
  • 2016.11
    TCRCure Chongqing R&D center established
    Obtain angel investment from professional investment institutions.
  • 2017.05
    TCRCure US center established.
  • 2018.01
    Planned for 20+ cell therapy related IP assets
    Completed preclinical studies for 5 pipeline products
  • 2018.04
    POC clinical trial started: TCR-T therapy for cervical and head/neck cancer
  • 2019.01
    Obtain series A funding from professional pharmaceutical factories and investment institutions
    TCRCure US and China GMP Center started construction.
  • 2019.01
    POC clinical trial started in Xinqiao Hospital: TCR-T with secreted PD1 products for cervical and nasopharynx cancer therapy。
  • 2019.08
    POC clinical trial started in Sun Yat-sen University Cancer Center: TCR-T product for nasopharynx cancer therapy.
  • 2019.12
    TCRCure US and China GMP Center completed.
    Two clinical trials for cervical and nasopharyngeal cancer were conducted in China

Copyright © 2019 TCR CURE Biopharma Technology Co., Ltd Powered by vancheer
Introduction to TCRCure
Immune Cell Therapy
Product and Services
News
Recruitment

Copyright © 2019 TCR CURE Biopharma Technology Co., Ltd Powered by vancheer